Apriem Advisors’s Zogenix, Inc. ZGNX Stock Holding History

Apriem Advisors’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-312	Closed	-$3K	–	681
2016 Q1	$3K	Buy	+312	New	+$3.13K	﹤0.01%	510

Other funds holding ZGNX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Apriem Advisors's ZGNX Position: Q2 2016 in Review

Apriem Advisors sold out of Zogenix, Inc. (ZGNX) in Q2 2016, closing a stake of 312 shares — an estimated $3K sold.

Apriem Advisors first reported a position in ZGNX in Q1 2016 and held it in 1 quarter. The position peaked at $3K in Q1 2016. 84 funds tracked by Wall St. Rank hold ZGNX as of Q2 2016.

Apriem Advisors reported no remaining Zogenix, Inc. position as of Q2 2016 after selling out during the quarter.
Apriem Advisors sold 312 Zogenix, Inc. shares in Q2 2016, an estimated $3K.
Apriem Advisors first reported a position in Zogenix, Inc. in Q1 2016 and held it in 1 quarter.
Apriem Advisors's Zogenix, Inc. position peaked at $3K in Q1 2016.
84 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q2 2016.

Based on Apriem Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.